<p><strong>在《危重症探索》上发表的研究强调了单孔导管设计对高碳酸血症患者的益处 1</strong></p>
<p>, /PRNewswire/ -- Vapotherm, Inc.，全球领先的无面罩非侵入性呼吸支持公司，自豪地宣布在《危重症探索》上发表了一项新的临床研究，题为《高流速治疗的单孔导管设计效果：在较低气体流量下的可比疗效》。该研究表明，ProSoft® Unicorn™ 导管作为一种单孔高流速治疗导管，在显著较低的流量下提供了与传统双孔导管相当的呼吸困难缓解效果。</p>
<p>该研究由查尔斯·阿特伍德博士领导，评估了 26 名高碳酸血症慢性阻塞性肺病（COPD）患者的随机交叉试验。结果显示，使用独角兽导管的患者在中位流量仅为 15 LPM 时体验到的呼吸困难缓解效果与传统双孔导管的 25 LPM 相当。</p>
<p>“鼻导管的孔径大小很重要。通过用高流速的新鲜气体冲洗上呼吸道的死腔，HVT 改善了通气并减少了呼吸的工作量，” Vapotherm 首席医疗官杰西卡·惠特尔博士说。“作为一名急诊医生，看到单孔导管在成人患者中得到应用，令人感到非常兴奋——包括那些有鼻骨骨折、唇腭裂、鼻胃管和其他挑战的患者。”</p>
<p><strong>呼吸护理效率的新标准</strong></p>
<p>该研究的一个重要发现是氧气节约的潜力，使独角兽导管成为乡村医院、国际医疗环境和未来需要有效治疗的居家患者的理想选择，同时减少氧气消耗。</p>
<p>“我们很高兴看到独角兽导管在较低流量下提供相同的临床益处，” Vapotherm 总裁兼首席执行官乔·阿米说。“对于氧气有限的设施、医院内患者的转运以及居家患者，这意味着一种更可持续和舒适的治疗选择。全天更换鼻孔的患者可能会体验到更少的刺激，从而提高依从性——同时保持有效的二氧化碳清除。”</p>
<p><strong>研究的关键要点：</strong></p>
<ul>
<li><strong>在较低流量下可比的呼吸困难缓解：</strong> 独角兽导管在较低流量下实现了与传统双孔导管相似的呼吸困难缓解效果。</li>
<li><strong>增强的舒适性和多功能性：</strong> 独角兽导管是面部畸形、创伤患者和需要鼻胃管的患者的选择，为双孔系统提供了有效的替代方案。</li>
<li><strong>增加的舒适性可能意味着未来居家患者的依从性提高：</strong> 单孔设计允许患者在两个鼻孔之间交替使用，以减少刺激。</li>
</ul>
<p><strong>扩展对高流速治疗的临床理解</strong></p>
<p>该研究现已在《危重症探索》上发布，进一步支持高流速治疗作为自发呼吸患者非侵入性通气的替代方案。</p>
<p>有兴趣了解更多的医疗专业人士可以在此访问完整出版物：<em>危重症探索研究链接</em></p>
<p>有关独角兽导管的更多信息或探索其如何增强患者护理，请访问 Vapotherm.com 或联系 [email protected] 以获取任何问题。</p>
<p><strong>关于 Vapotherm</strong></p>
<p>Vapotherm, Inc. 总部位于新罕布什尔州埃克塞特，致力于通过创新和临床卓越改善呼吸护理。通过开发高流速治疗等先进解决方案，Vapotherm 使医疗提供者能够提供卓越的患者结果，同时提升护理体验并降低整体护理成本。</p>
<ol>
<li>Atwood, Charles MD; Sethi, Jigme MD; Bergeski, Amy MHA, RRT-NPS; Dungan, George C. II MPhil (Med); Volakis, Leonithas I. MS, PhD; Whittle, Jessica S. MD, PhD. 高流速治疗的单孔导管设计效果：在较低气体流量下的可比疗效。《危重症探索》7(2):p e1209, 2025 年 2 月。| DOI: 10.1097/CCE.0000000000001209</li>
</ol>
<p>来源 Vapotherm, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNTIwJk5ld3NJdGVtSWQ9REM5MTEyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA1MjAwNjMwUFJfTkVXU19VU1BSX19fX19EQzkxMTIx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNTIwJk5ld3NJdGVtSWQ9REM5MTEyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA1MjAwNjMwUFJfTkVXU19VU1BSX19fX19EQzkxMTIx"/></p>

VAPO

<p>Vapotherm, Inc. 宣布了一项新的临床研究，该研究发表在《重症监护探索》期刊上，表明其 ProSoft® Unicorn™ 导管在较低流量（15 LPM）下提供的呼吸困难缓解效果与传统双孔导管（25 LPM）相当。该研究由 Charles Atwood 医生主导，涉及 26 名高碳酸血症的慢性阻塞性肺病患者，突显了该导管对面部畸形患者和需要鼻胃管的患者的益处。研究结果表明，可能实现氧气节约，使其适合农村医院和居家护理环境，提高患者的舒适度和依从性</p>

<p><strong>Published Research in <em>Critical Care Explorations</em> Highlights Benefits of Single-Prong Cannula Design for Hypercapnic Patients1</strong></p>
<div class="lb-trans"><p><strong>在《危重症探索》上发表的研究强调了单孔导管设计对高碳酸血症患者的益处 1</strong></p>
</div><p>, /PRNewswire/ -- Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, <em>Effect of Single-Prong Cannula Design with High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates</em>, in <em>Critical Care Explorations</em>. The study demonstrates that the ProSoft® Unicorn™ Cannula, a single-prong high velocity therapy cannula, provides comparable relief of dyspnea at significantly lower flow rates compared to traditional dual-prong cannulas.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Vapotherm, Inc.，全球领先的无面罩非侵入性呼吸支持公司，自豪地宣布在《危重症探索》上发表了一项新的临床研究，题为《高流速治疗的单孔导管设计效果：在较低气体流量下的可比疗效》。该研究表明，ProSoft® Unicorn™ 导管作为一种单孔高流速治疗导管，在显著较低的流量下提供了与传统双孔导管相当的呼吸困难缓解效果。</p>
</div><p>The study, led by Dr. Charles Atwood, evaluated 26 hypercapnic COPD patients in a randomized crossover trial. The results showed that patients using the Unicorn Cannula experienced comparable relief of dyspnea at a median flow rate of just 15 LPM, compared to 25 LPM for traditional dual-prong cannulas.</p>
<div class="lb-trans"><p>该研究由查尔斯·阿特伍德博士领导，评估了 26 名高碳酸血症慢性阻塞性肺病（COPD）患者的随机交叉试验。结果显示，使用独角兽导管的患者在中位流量仅为 15 LPM 时体验到的呼吸困难缓解效果与传统双孔导管的 25 LPM 相当。</p>
</div><p>&#34;The bore-size of a nasal cannula matters. By flushing the upper airway dead space with high velocity fresh gas, HVT improves ventilation and reduces the work of breathing,&#34; said Dr. Jessica Whittle, Chief Medical Officer at Vapotherm. &#34;As a practicing emergency physician, it's so exciting to see a single prong cannula in the adult space for all patients – including those with broken noses, cleft palates, NG tubes, and other challenges.&#34;</p>
<div class="lb-trans"><p>“鼻导管的孔径大小很重要。通过用高流速的新鲜气体冲洗上呼吸道的死腔，HVT 改善了通气并减少了呼吸的工作量，” Vapotherm 首席医疗官杰西卡·惠特尔博士说。“作为一名急诊医生，看到单孔导管在成人患者中得到应用，令人感到非常兴奋——包括那些有鼻骨骨折、唇腭裂、鼻胃管和其他挑战的患者。”</p>
</div><p><strong>A New Standard for Efficiency in Respiratory Care</strong></p>
<div class="lb-trans"><p><strong>呼吸护理效率的新标准</strong></p>
</div><p>One of the most significant findings of the study is the potential for oxygen conservation, making the Unicorn Cannula an ideal option for rural hospitals, international healthcare settings, and future home care patients who need effective therapy while reducing oxygen consumption.</p>
<div class="lb-trans"><p>该研究的一个重要发现是氧气节约的潜力，使独角兽导管成为乡村医院、国际医疗环境和未来需要有效治疗的居家患者的理想选择，同时减少氧气消耗。</p>
</div><p>&#34;We're excited to see the Unicorn Cannula delivering the same clinical benefit at lower flow rates,&#34; said Joe Army, President and CEO of Vapotherm. &#34;For oxygen-limited facilities, transport of patients within the hospital, and for home patients, this can mean a more sustainable and comfortable therapy option. Patients who switch nostrils throughout the day may experience less irritation leading to greater compliance—all while maintaining effective CO₂ clearance.&#34;</p>
<div class="lb-trans"><p>“我们很高兴看到独角兽导管在较低流量下提供相同的临床益处，” Vapotherm 总裁兼首席执行官乔·阿米说。“对于氧气有限的设施、医院内患者的转运以及居家患者，这意味着一种更可持续和舒适的治疗选择。全天更换鼻孔的患者可能会体验到更少的刺激，从而提高依从性——同时保持有效的二氧化碳清除。”</p>
</div><p><strong>Key Takeaways from the Study:</strong></p>
<div class="lb-trans"><p><strong>研究的关键要点：</strong></p>
</div><ul>
<li><strong>Comparable Dyspnea Relief at Lower Flow Rates:</strong> The Unicorn Cannula achieved similar dyspnea relief as traditional dual-prong cannulas at lower flow rates.</li>
<li><strong>Enhanced Comfort and Versatility:</strong> The Unicorn Cannula is an option for patients with facial deformities, trauma and for those requiring nasogastric tubes, offering an effective alternative to dual-prong systems.</li>
<li><strong>Increased Comfort may mean increased Compliance for Future Home Patients:</strong> The single-prong design allows patients to alternate the nasal prong from one naris to the other to minimize irritation.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>在较低流量下可比的呼吸困难缓解：</strong> 独角兽导管在较低流量下实现了与传统双孔导管相似的呼吸困难缓解效果。</li>
<li><strong>增强的舒适性和多功能性：</strong> 独角兽导管是面部畸形、创伤患者和需要鼻胃管的患者的选择，为双孔系统提供了有效的替代方案。</li>
<li><strong>增加的舒适性可能意味着未来居家患者的依从性提高：</strong> 单孔设计允许患者在两个鼻孔之间交替使用，以减少刺激。</li>
</ul>
</div><p><strong>Expanding the Clinical Understanding of High-Velocity Therapy</strong></p>
<div class="lb-trans"><p><strong>扩展对高流速治疗的临床理解</strong></p>
</div><p>The study, now available in <em>Critical Care Explorations</em>, adds to the growing body of evidence supporting high velocity therapy as an alternative to non-invasive ventilation, for spontaneously breathing patients.</p>
<div class="lb-trans"><p>该研究现已在《危重症探索》上发布，进一步支持高流速治疗作为自发呼吸患者非侵入性通气的替代方案。</p>
</div><p>Healthcare professionals interested in learning more can access the full publication here: <em>Critical Care Explorations Study Link</em></p>
<div class="lb-trans"><p>有兴趣了解更多的医疗专业人士可以在此访问完整出版物：<em>危重症探索研究链接</em></p>
</div><p>For more information about the Unicorn Cannula or to explore how it can enhance patient care, visit Vapotherm.com or contact [email protected] for any questions.</p>
<div class="lb-trans"><p>有关独角兽导管的更多信息或探索其如何增强患者护理，请访问 Vapotherm.com 或联系 [email protected] 以获取任何问题。</p>
</div><p><strong>About Vapotherm</strong></p>
<div class="lb-trans"><p><strong>关于 Vapotherm</strong></p>
</div><p>Vapotherm, Inc. based in Exeter, NH, is dedicated to improving respiratory care through innovation and clinical excellence. By developing advanced solutions like high velocity therapy, Vapotherm empowers healthcare providers to deliver superior patient outcomes while enhancing the care experience and reducing the total cost of care.</p>
<div class="lb-trans"><p>Vapotherm, Inc. 总部位于新罕布什尔州埃克塞特，致力于通过创新和临床卓越改善呼吸护理。通过开发高流速治疗等先进解决方案，Vapotherm 使医疗提供者能够提供卓越的患者结果，同时提升护理体验并降低整体护理成本。</p>
</div><ol>
<li>Atwood, Charles MD; Sethi, Jigme MD; Bergeski, Amy MHA, RRT-NPS; Dungan, George C. II MPhil (Med); Volakis, Leonithas I. MS, PhD; Whittle, Jessica S. MD, PhD. Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates. Critical Care Explorations 7(2):p e1209, February 2025. | DOI: 10.1097/CCE.0000000000001209</li>
</ol>
<div class="lb-trans"><ol>
<li>Atwood, Charles MD; Sethi, Jigme MD; Bergeski, Amy MHA, RRT-NPS; Dungan, George C. II MPhil (Med); Volakis, Leonithas I. MS, PhD; Whittle, Jessica S. MD, PhD. 高流速治疗的单孔导管设计效果：在较低气体流量下的可比疗效。《危重症探索》7(2):p e1209, 2025 年 2 月。| DOI: 10.1097/CCE.0000000000001209</li>
</ol>
</div><p>SOURCE Vapotherm, Inc.</p>
<div class="lb-trans"><p>来源 Vapotherm, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNTIwJk5ld3NJdGVtSWQ9REM5MTEyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA1MjAwNjMwUFJfTkVXU19VU1BSX19fX19EQzkxMTIx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC91121&amp;Transmission_Id=202505200630PR_NEWS_USPR_____DC91121&amp;DateId=20250520"/></p>

新的研究证实 Vapotherm 的 Unicorn™鼻导管在较低流速下提供了相当的疗效